The study is enrolling participants to see if the disitamab vedotin works to treat bladder cancer when used alone or when it is used in combination with pembrolizumab.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Matthew Milowsky
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Bladder)
24-0407